First recorded at the 2nd annual Drug Delivery West conference, Dr Carlos Schuler, InCarda Therapeutics discusses transforming cardiovascular treatment with pulmonary delivery. This podcast discusses:

Pioneering a novel approach for treating cardiovascular conditions by the oral inhalation route
Will be the ONLY non-invasive, self administered product for acute management of Paroxysmal Atrial Fibrilation, providing rapid cardioversion
In Phase 2: Dose dependent conversion observed
Working on enhancements to greatly improve speed of delivery

To learn more about the 3rd annual Drug Delivery West conference happening May 17-18, 2021 in San Francisco, CA please visit www.drugdeliverywest.org

Transforming Cardiovascular Treatment with Pulmonary Delivery

Share

Embed